Development of herpetrione nanosuspensions stabilized by glycyrrhizin for enhancing bioavailability and synergistic hepatoprotective effect

References

• Jog R, Burgess DJ. Pharmaceutical amorphous nanoparticles. J Pharm Sci. 2017;106(1):39–65.
   PubMed Web of Science ®Google Scholar
• Jacob S, Nair AB, Shah J. Emerging role of nanosuspensions in drug delivery systems. Biomater Res. 2020;24:3.
   PubMedGoogle Scholar
• Lai F, Schlich M, Pireddu R, et al. Nanocrystals as effective delivery systems of poorly water-soluble natural molecules. Curr Med Chem. 2019;26(24):4657–4680.
   PubMed Web of Science ®Google Scholar
• Shen B, Shen C, Zhu W, et al. The contribution of absorption of integral nanocrystals to enhancement of oral bioavailability of quercetin. Acta Pharm Sin B. 2021;11(4):978–988.
   PubMed Web of Science ®Google Scholar
• Wang XH, Liu Y, Shen CY, et al. Effect of particle size on the in vitro and in vivo behavior of astilbin nanosuspensions. J Drug Deliv Sci Tec. 2019;52:778–783.
   Web of Science ®Google Scholar
• Tu L, Cheng M, Sun Y, et al. Fabrication of ultra-small nanocrystals by formation of hydrogen bonds: in vitro and in vivo evaluation. Int J Pharm. 2020;573:118730.
   PubMedGoogle Scholar
• Shen B, Wu N, Shen C, et al. Hyperoside nanocrystals for HBV treatment: process optimization, in vitro and in vivo evaluation. Drug Dev Ind Pharm. 2016;42(11):1772–1781.
   PubMed Web of Science ®Google Scholar
• Yue PF, Li Y, Wan J, et al. Process optimization and evaluation of novel baicalin solid nanocrystals. Int J Nanomedicine. 2013;8:2961–2973.
   PubMed Web of Science ®Google Scholar
• Gigliobianco MR, Casadidio C, Censi R, et al. Nanocrystals of poorly soluble drugs: drug bioavailability and physicochemical stability. Pharmaceutics. 2018;10(3):134.
   PubMed Web of Science ®Google Scholar
• Mohammad IS, Hu H, Yin L, et al. Drug nanocrystals: fabrication methods and promising therapeutic applications. Int J Pharm. 2019;562:187–202.
   PubMedGoogle Scholar
• Ahire E, Thakkar S, Darshanwad M, et al. Parenteral nanosuspensions: a brief review from solubility enhancement to more novel and specific applications. Acta Pharm Sin B. 2018;8(5):733–755.
   PubMed Web of Science ®Google Scholar
• Patel D, Zode SS, Bansal AK. Formulation aspects of intravenous nanosuspensions. Int J Pharm. 2020;586:119555.
   PubMed Web of Science ®Google Scholar
• Patel V, Sharma OP, Mehta T. Nanocrystal: a novel approach to overcome skin barriers for improved topical drug delivery. Expert Opin Drug Deliv. 2018;15(4):351–368.
   PubMed Web of Science ®Google Scholar
• Liu T, Yu X, Yin H, et al. Advanced modification of drug nanocrystals by using novel fabrication and downstream approaches for tailor-made drug delivery. Drug Deliv. 2019;26(1):1092–1103.
   PubMed Web of Science ®Google Scholar
• Dhaval M, Makwana J, Sakariya E, et al. Drug nanocrystals: a comprehensive review with current regulatory guidelines. Curr Drug Deliv. 2020;17(6):470–482.
   PubMed Web of Science ®Google Scholar
• Yang H, Kim H, Jung S, et al. Pharmaceutical strategies for stabilizing drug nanocrystals. Curr Pharm Des. 2018;24(21):2362–2374.
   PubMed Web of Science ®Google Scholar
• Tuomela A, Hirvonen J, Peltonen L. Stabilizing agents for drug nanocrystals: effect on bioavailability. Pharmaceutics. 2016;8(2):16.
   PubMed Web of Science ®Google Scholar
• Wang L, Du J, Zhou Y, et al. Safety of nanosuspensions in drug delivery. Nanomedicine. 2017;13(2):455–469.
   PubMed Web of Science ®Google Scholar
• He W, Lu Y, Qi J, et al. Food proteins as novel nanosuspension stabilizers for poorly water-soluble drugs. Int J Pharm. 2013;441(1–2):269–278.
   PubMed Web of Science ®Google Scholar
• He W, Lu Y, Qi J, et al. Formulating food protein-stabilized indomethacin nanosuspensions into pellets by fluid-bed coating technology: physical characterization, redispersibility, and dissolution. Int J Nanomedicine. 2013;8:3119–3128.
   PubMed Web of Science ®Google Scholar
• Aditya NP, Yang H, Kim S, et al. Fabrication of amorphous curcumin nanosuspensions using β-lactoglobulin to enhance solubility, stability, and bioavailability. Colloids Surf B Biointerfaces. 2015;127:114–121.
   PubMed Web of Science ®Google Scholar
• Geng T, Banerjee P, Lu Z, et al. Comparative study on stabilizing ability of food protein, non-ionic surfactant and anionic surfactant on BCS type II drug carvedilol loaded nanosuspension: physicochemical and pharmacokinetic investigation. Eur J Pharm Sci. 2017;109:200–208.
   PubMed Web of Science ®Google Scholar
• Lu Y, Wang ZH, Li T, et al. Development and evaluation of transferrin-stabilized paclitaxel nanocrystal formulation. J Control Release. 2014;176:76–85.
   PubMed Web of Science ®Google Scholar
• Yin T, Dong L, Cui B, et al. A toxic organic solvent-free technology for the preparation of PEGylated paclitaxel nanosuspension based on human serum albumin for effective cancer therapy. Int J Nanomedicine. 2015;10:7397–7412.
   PubMed Web of Science ®Google Scholar
• Yin T, Cai H, Liu J, et al. Biological evaluation of PEG modified nanosuspensions based on human serum albumin for tumor targeted delivery of paclitaxel. Eur J Pharm Sci. 2016;83:79–87.
   PubMed Web of Science ®Google Scholar
• Xie Y, Ma Y, Xu J, et al. Panax notoginseng saponins as a novel nature stabilizer for poorly soluble drug nanocrystals: a case study with baicalein. Molecules. 2016;21(9):1149.
   Web of Science ®Google Scholar
• Chen Y, Liu Y, Xu J, et al. A natural triterpenoid saponin as multifunctional stabilizer for drug nanosuspension powder. AAPS PharmSciTech. 2017;18(7):2744–2753.
   PubMed Web of Science ®Google Scholar
• Jin X, Luo Y, Chen Y, et al. Novel breviscapine nanocrystals modified by panax notoginseng saponins for enhancing bioavailability and synergistic anti-platelet aggregation effect. Colloids Surf B Biointerfaces. 2019;175:333–342.
   PubMed Web of Science ®Google Scholar
• Long J, Song J, Zhang X, et al. Tea saponins as natural stabilizers for the production of hesperidin nanosuspensions. Int J Pharm. 2020;583:119406.
   PubMedGoogle Scholar
• Jiang M, Zhao S, Yang S, et al. An "essential herbal medicine"-licorice: a review of phytochemicals and its effects in combination preparations. J Ethnopharmacol. 2020;249:112439.
   PubMed Web of Science ®Google Scholar
• Yang FH, Zhang Q, Liang QY, et al. Bioavailability enhancement of paclitaxel via a novel oral drug delivery system: paclitaxel-loaded glycyrrhizic acid micelles. Molecules. 2015;20(3):4337–4356.
   PubMed Web of Science ®Google Scholar
• Shen C, Shen B, Zhu J, et al. Glycyrrhizic acid-based self-assembled micelles for improving oral bioavailability of paeoniflorin. Drug Dev Ind Pharm. 2021;47(2):207–214.
   PubMed Web of Science ®Google Scholar
• Chen K, Yang R, Shen FQ, et al. Advances in pharmacological activities and mechanisms of glycyrrhizic acid. Curr Med Chem. 2020;27(36):6219–6243.
   PubMed Web of Science ®Google Scholar
• Li JY, Cao HY, Liu P, et al. Glycyrrhizic acid in the treatment of liver diseases: literature review. Biomed Res Int. 2014;2014(872139):872139.
   PubMedGoogle Scholar
• Kaouadji M, Favre-Bonvin J. Herpetrione, lignoide trimere isole d'herpetospermum caudigerum. Tetrahedron Lett. 1983;24(52):5881–5884.
   Web of Science ®Google Scholar
• Yuan H-L, Yang M, Li X-Y, et al. Hepatitis B virus inhibiting constituents from herpetospermum caudigerum. Chem Pharm Bull. 2006;54(11):1592–1594.
   PubMed Web of Science ®Google Scholar
• Shen B, Chen H, Shen C, et al. Hepatoprotective effects of lignans extract from herpetospermum caudigerum against CCl4-induced acute liver injury in mice. J Ethnopharmacol. 2015;164:46–52.
   PubMed Web of Science ®Google Scholar
• Yuan HL, Guo JJ, Li XY, et al. Preparation and application of herperione and its capsule. China PatentCN102040101A. 2011 Aug 3.
   Google Scholar
• Shen C, Shen B, Liu X, et al. Nanosuspensions based gel as delivery system of nitrofurazone for enhanced dermal bioavailability. J Drug Deliv Sci Tec. 2018;43:1–11.
   Web of Science ®Google Scholar
• Liu X, Shen B, Shen C, et al. Nanoparticle-loaded gels for topical delivery of nitrofurazone: effect of particle size on skin permeation and retention. J Drug Deliv Sci Tec. 2018;45:367–372.
   Web of Science ®Google Scholar
• Guo JJ, Yue PF, Lv JL, et al. Development and in vivo/in vitro evaluation of novel herpetrione nanosuspension. Int J Pharm. 2013;441(1–2):227–233.
   PubMed Web of Science ®Google Scholar
• Shen B, Shen C, Xu L, et al. Ultrasound exposure ameliorates the hepatoprotective effect of herpetrione nanosuspension via oral delivery. J Drug Deliv Sci Tec. 2019;49:82–88.
   Web of Science ®Google Scholar
• Xu Y, Liu X, Lian R, et al. Enhanced dissolution and oral bioavailability of aripiprazole nanosuspensions prepared by nanoprecipitation/homogenization based on acid-base neutralization. Int J Pharm. 2012;438(1–2):287–295.
   PubMedGoogle Scholar
• Wang WP, Liu ZZ, Chang DX, et al. Gelation properties of glycyrrhizin aqueous solution. Chin J Hosp Pharm. 2020;40:1724–1727.
   Google Scholar
• Shen C, Zhu J, Song J, et al. Formulation of pluronic F127/TPGS mixed micelles to improve the oral absorption of glycyrrhizic acid. Drug Dev Ind Pharm. 2020;46(7):1100–1107.
   PubMed Web of Science ®Google Scholar
• Lu XY, Lu XY, Zhang ZH, et al. Preparation and characterization of honokiol nanosuspensions and preliminary evaluation of anti-Inflammatory effect. AAPS PharmSciTech. 2020;21(2):62.
   PubMed Web of Science ®Google Scholar
• Xie Y, Shi B, Xia F, et al. Epithelia transmembrane transport of orally administered ultrafine drug particles evidenced by environment sensitive fluorophores in cellular and animal studies. J Control Release. 2018;270:65–75.
   PubMed Web of Science ®Google Scholar
• Shen C, Yang Y, Shen B, et al. Self-discriminating fluorescent hybrid nanocrystals: efficient and accurate tracking of translocation via oral delivery. Nanoscale. 2018;10(1):436–450.
   Web of Science ®Google Scholar